These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 29034691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe.
    Lee BC, Liu KL, Wu CH, Huang KW, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH, Liang PC.
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1699-1707. PubMed ID: 29946941
    [Abstract] [Full Text] [Related]

  • 8. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
    Haochen W, Jian W, Li S, Tianshi L, Xiaoqiang T, Yinghua Z.
    J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022
    [Abstract] [Full Text] [Related]

  • 9. Multiple imaging modality-guided radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma in special locations.
    Yang BS, Liu LX, Yuan M, Hou YB, Li QT, Zhou S, Shi YX, Gao BL.
    Diagn Interv Radiol; 2020 Mar; 26(2):131-139. PubMed ID: 32071022
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
    Liu B, Long J, Wang W, Huang G, Jiang C, Zhang X, Liu M, Liang P, Yu J, Xie X, Kuang M.
    Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
    [Abstract] [Full Text] [Related]

  • 11. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY, Zhang JL, Wang MQ, Yuan K, Bai YH, Wang Y, Xin HN, Wang ZJ, Liu FY, Duan F, Fu JX.
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [Abstract] [Full Text] [Related]

  • 12. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 13. Combined transarterial chemoembolization of the right inferior phrenic artery and radiofrequency ablation for small hepatocellular carcinoma near the diaphragm: its efficacy and safety.
    Hyun D, Cho SK, Shin SW, Park KB, Lee SY, Park HS, Choo SW, Do YS.
    Abdom Radiol (NY); 2018 Oct; 43(10):2851-2858. PubMed ID: 29492603
    [Abstract] [Full Text] [Related]

  • 14. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
    El-Kady NM, Esmat G, Mahmoud EH, Darweesh SK, Mahmoud SH, Elagawy WA.
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A).
    Lee H, Yoon CJ, Seong NJ, Jeong SH, Kim JW.
    Korean J Radiol; 2018 May; 19(6):1130-1139. PubMed ID: 30386144
    [Abstract] [Full Text] [Related]

  • 16. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M.
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [Abstract] [Full Text] [Related]

  • 18. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas.
    Zuo TY, Liu FY, Wang MQ, Chen XX.
    Chin Med J (Engl); 2017 Nov 20; 130(22):2666-2673. PubMed ID: 29133753
    [Abstract] [Full Text] [Related]

  • 19. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH, Kim PN, Won HJ, Shin YM.
    AJR Am J Roentgenol; 2014 Nov 20; 203(5):1127-31. PubMed ID: 25341154
    [Abstract] [Full Text] [Related]

  • 20. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA.
    Asian Pac J Cancer Prev; 2016 Nov 20; 17(9):4349-4352. PubMed ID: 27797242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.